NCT02461693View on ClinicalTrials.gov

Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
CaffeineAffectCognitive Ability, GeneralMood
Interventions
DRUG

Caffeine

200mg delivered as pill; one-time dose

DRUG

Placebo

Lactose-based pill; one-time dose

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02461693 - Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT | Biotech Hunter | Biotech Hunter